Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Keryx Biopharmaceuticals, Inc. (NQ: KERX)
7.940 USD  -0.110 (-1.37%)
Streaming Delayed Price  /  Updated: 3:03 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Keryx Biopharmaceuticals, Inc.
 
< Previous 1 2
...
31 32 33 34 35 36 37 38 Next >
StockPreacher.com Issues Trading Outlook for Keryx Biopharmaceuticals Inc.
August 10, 2009
from GlobeNewswire News Releases
Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
August 05, 2009
from PR Newswire
Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
August 04, 2009
from PR Newswire
Keryx (KERX) Settles Dispute With Alfa Wassermann; To Receive $3.5M Payment
August 04, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4841354 for the full story. Read More
from StreetInsider.com News Articles
Market Pulse Breaking News Alert for Tuesday, August 4, 2009: MNGA -- MagneGas Receives Its Most Significant Independent Media Attention to Date in the Form of a Feature Article in Welding Journal!
August 04, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse. Read More
from Marketwired News Releases
Keryx Biopharmaceuticals Settles License Dispute With Alfa Wassermann
August 04, 2009
from PR Newswire
Keryx Moves Forward With Study
August 03, 2009
Shares of Keryx Biopharmaceuticals Inc. (Nasdaq: KERX) leaped 46 cents to close at $1.61 after the FDA allowed the company to move forward with late-stage study of its cancer drug candidate.  ... Read More
from MarketMinute.com Stock News
Unusual 11 Mid-Day Movers 8/3: PCAP, TSPT, KERX, GGC Higher; HURN, RPRX, SVNT, CSCX Lower
August 03, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4838336 for the full story. Read More
from StreetInsider.com News Articles
Stocks Open Higher on Hopes of Economic Recovery
August 03, 2009
The markets opened higher as investors turned cautiously optimistic about signals that automotive and banking industries may be on the mend. The Dow rose 46 points to 9217 while Nasdaq added 11 points... Read More
category Market News
from MarketMinute.com Market Updates
Morning Movers 8/3: KERX, TSPT, TSEM, ICAD, AMFI Higher; HURN, RPRX, ADAT, SVNT Lower
August 03, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4837790 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals (KERX) Jumps On FDA Agreement
August 03, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4837786 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharma (KERX) Reaches Agreement with FDA on SPA for Phase 3 Trial of KRX-0401
August 03, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4837682 for the full story. Read More
from StreetInsider.com News Articles
AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
August 03, 2009
from PR Newswire
Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma
August 03, 2009
from PR Newswire
Beacon Equity Issues Investment Report for Keryx Biopharmaceuticals Inc.
July 17, 2009
from GlobeNewswire News Releases
Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
July 14, 2009
from PR Newswire
BridgewaterEquity.com Free Fundamental Sector & Market Research on SHFL, FWLT, IPCR, CASY, KERX and FULT
July 14, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Bridgewater Equity (BWE). Read More
from Marketwired News Releases
TheFortuneFinancial.com Free Market Research on HLTH, IBKR, ACLS, SOLF, KERX and ICON
June 29, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com. Read More
from Marketwired News Releases
Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
June 17, 2009
from PR Newswire
PennyStockExplosion.com Issues Technical Trade Alerts on Cancer Stocks on the Move Today: HEB, GNBT, CTIC, KERX, DNDN
June 15, 2009
from PR Newswire
Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
June 09, 2009
from PR Newswire
Positive Trial Results For Keryx's Zerenex
June 08, 2009
Keryx Biopharmaceuticals Inc. (Nasdaq: KERX) reported positive results for a Phase 2 clinical trial of its end-stage renal disease treatment Zerenex. The stock price climbed 21 cents to $1.29.  ... Read More
from MarketMinute.com Stock News
Unusual 11 Mid-Day Movers 6/8: ANPI, MFRI, RSOL, KERX Higher; XTNT, EMIS, AGEN, AIB Lower
June 08, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4715013 for the full story. Read More
from StreetInsider.com News Articles
Falling Commodities Prices Weigh Down Markets
June 08, 2009
Fallling commodities prices weighed down the markets during the midday with the Dow tumbling 99 points to 8663. Nasdaq fell 24points to 1824. Read More
category Market News
from MarketMinute.com Market Updates
Drug stocks slip; Lundbeck tumbles on studies
June 08, 2009
Drug stocks slip in early action as shares of H. Lundbeck A/S tumble on news that late-stage clinical studies for its antidepressant LuAA21004 had yielded disappointing results. Read More
category Biotechnology , $DRG , HLUKY , and 7 more.
from MarketWatch
Morning Movers 6/8: ANPI, MITI, KERX, DYAX, MSPD, MNKD Higher; AIB, LYG, XTNT, IRE Lower
June 08, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4714145 for the full story. Read More
from StreetInsider.com News Articles
WallStSense.com Free Research Report for Shareholders of LVS, CVX, MDT and KERX
June 08, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com Read More
from Marketwired News Releases
ANPI, STEM, CTIC, KERX, XOMA, MITI, MBRX See Volume and Upside Price Action
June 08, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4714064 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals (KERX) Announces Positive Phase 2 Study of Zerenex
June 08, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4713807 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients
June 08, 2009
from PR Newswire
< Previous 1 2
...
31 32 33 34 35 36 37 38 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here